{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:11:07Z","timestamp":1761059467778},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.pupt.2013.01.005","type":"journal-article","created":{"date-parts":[[2013,1,20]],"date-time":"2013-01-20T08:30:11Z","timestamp":1358670611000},"page":"336-341","source":"Crossref","is-referenced-by-count":13,"title":["Multidetector-row computed tomography assessment of adding budesonide\/formoterol to tiotropium in patients with chronic obstructive pulmonary disease"],"prefix":"10.1016","volume":"26","author":[{"given":"Hideki","family":"Yasui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Inui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Furuhashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaro","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Uto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumasa","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Takehara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Suda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kingo","family":"Chida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pupt.2013.01.005_bib1","unstructured":"Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the\u00a0diagnosis, management, and prevention of chronic obstructive lung disease. Updated 2011. http:\/\/www.goldcopd.org\/guidelines-global-strategy-for-diagnosis-management.html [accessed 20.09.12]."},{"key":"10.1016\/j.pupt.2013.01.005_bib2","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1164\/rccm.200703-456SO","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary","volume":"176","author":"Rabe","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2013.01.005_bib3","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1164\/rccm.200907-1008OC","article-title":"Quantitative computed tomography measures of emphysema and airway wall thickness are related to respiratory symptoms","volume":"181","author":"Grydeland","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2013.01.005_bib4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1475-097X.2011.01046.x","article-title":"Response patterns to bronchodilator and quantitative computed tomography in chronic obstructive pulmonary disease","volume":"32","author":"Lee","year":"2012","journal-title":"Clin Physiol Funct Imaging"},{"key":"10.1016\/j.pupt.2013.01.005_bib5","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1183\/09031936.00099306","article-title":"Outcomes for COPD pharmacological trials: from lung function to biomarkers","volume":"31","author":"Cazzola","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2013.01.005_bib6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00408-011-9353-9","article-title":"Quantitative computed tomography in COPD: possibilities and limitations","volume":"190","author":"Mets","year":"2012","journal-title":"Lung"},{"key":"10.1016\/j.pupt.2013.01.005_bib7","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.rmed.2010.02.023","article-title":"Relationship of emphysema and airway disease assessed by CT to exercise capacity in COPD","volume":"104","author":"Diaz","year":"2010","journal-title":"Respir Med"},{"key":"10.1016\/j.pupt.2013.01.005_bib8","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1513\/pats.200806-057QC","article-title":"Quantitative computed tomography assessment of airway wall dimensions: current status and potential applications for phenotyping chronic obstructive pulmonary disease","volume":"5","author":"Coxson","year":"2008","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.pupt.2013.01.005_bib9","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1136\/thx.2006.072777","article-title":"Characterisation of phenotypes based on severity of emphysema in chronic obstructive pulmonary disease","volume":"62","author":"Makita","year":"2007","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2013.01.005_bib10","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1183\/09031936.00159408","article-title":"Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha1-antitrypsin deficiency","volume":"33","author":"Dirksen","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2013.01.005_bib11","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1136\/thx.2008.103671","article-title":"Relationship between improved airflow limitation and changes in airway calibre induced by inhaled anticholinergic agents in COPD","volume":"64","author":"Hasegawa","year":"2009","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2013.01.005_bib12","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/thorax.55.4.289","article-title":"A\u00a0randomised controlled comparison of tiotropium and ipratropium in the treatment of chronic obstructive pulmonary disease. The Dutch Tiotropium Study Group","volume":"55","author":"van Noord","year":"2000","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2013.01.005_bib13","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJMoa0805800","article-title":"A\u00a04-year trial of tiotropium in chronic obstructive pulmonary disease","volume":"359","author":"Tashkin","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pupt.2013.01.005_bib14","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2147\/COPD.S4215","article-title":"Budesonide\/formoterol combination in COPD: a US perspective","volume":"5","author":"Sharafkhaneh","year":"2010","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.pupt.2013.01.005_bib15","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1378\/chest.129.3.509","article-title":"Effects of tiotropium with and without formoterol on airflow obstruction and resting hyperinflation in patients with COPD","volume":"129","author":"van Noord","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2013.01.005_bib16","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0140-6736(03)12459-2","article-title":"Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial","volume":"361","author":"Calverley","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.pupt.2013.01.005_bib17","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1378\/chest.124.3.834","article-title":"The efficacy and safety of fluticasone propionate (250 microg)\/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPD","volume":"124","author":"Hanania","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2013.01.005_bib18","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1056\/NEJMoa063070","article-title":"Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease","volume":"356","author":"Calverley","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pupt.2013.01.005_bib19","doi-asserted-by":"crossref","first-page":"545","DOI":"10.7326\/0003-4819-146-8-200704170-00152","article-title":"Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial","volume":"146","author":"Aaron","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pupt.2013.01.005_bib20","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1164\/rccm.200904-0492OC","article-title":"Efficacy and tolerability of budesonide\/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease","volume":"180","author":"Welte","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2013.01.005_bib21","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1164\/ajrccm\/145.6.1321","article-title":"A\u00a0self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire","volume":"145","author":"Jones","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.pupt.2013.01.005_bib22","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1164\/ajrccm.162.3.9907120","article-title":"Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function","volume":"162","author":"Nakano","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2013.01.005_bib23","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.clinimag.2009.05.004","article-title":"Assessment of COPD severity by computed tomography: correlation with lung functional testing","volume":"34","author":"Pauls","year":"2010","journal-title":"Clin Imaging"},{"key":"10.1016\/j.pupt.2013.01.005_bib24","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1378\/chest.94.4.782","article-title":"\u201cDensity mask\u201d. An objective method to quantitate emphysema using computed tomography","volume":"94","author":"Muller","year":"1988","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2013.01.005_bib25","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1164\/ajrccm.154.1.8680679","article-title":"Comparison of computed density and microscopic morphometry in pulmonary emphysema","volume":"154","author":"Gevenois","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2013.01.005_bib26","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1164\/rccm.200407-874OC","article-title":"The prediction of small airway dimensions using computed tomography","volume":"171","author":"Nakano","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2013.01.005_bib27","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1056\/NEJMoa032158","article-title":"The nature of small-airway obstruction in chronic obstructive pulmonary disease","volume":"350","author":"Hogg","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pupt.2013.01.005_bib28","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1164\/rccm.200601-037OC","article-title":"Airflow limitation and airway dimensions in chronic obstructive pulmonary disease","volume":"173","author":"Hasegawa","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2013.01.005_bib29","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1164\/rccm.200801-059OC","article-title":"Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease","volume":"178","author":"Patel","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2013.01.005_bib30","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1183\/09031936.00072511","article-title":"The acute effect of budesonide\/formoterol in COPD: a multi-slice computed tomography and lung function study","volume":"40","author":"De Backer","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2013.01.005_bib31","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1016\/j.jbiomech.2005.10.009","article-title":"Respiratory flow in obstructed airways","volume":"39","author":"Yang","year":"2006","journal-title":"J\u00a0Biomech"},{"key":"10.1016\/j.pupt.2013.01.005_bib32","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1164\/rccm.200508-1321OC","article-title":"Antiinflammatory effects of salmeterol\/fluticasone propionate in chronic obstructive lung disease","volume":"173","author":"Barnes","year":"2006","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553913000515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553913000515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T07:25:08Z","timestamp":1539933908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553913000515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S1094553913000515"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2013.01.005","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}